eHealth, Inc. (EHTH) 2024 Annual Report (10-K) Summary
Business Context and Reporting Period
This filing covers the fiscal year ended December 31, 2024. eHealth, Inc. operates as a leading private health insurance marketplace, utilizing an omnichannel platform to connect consumers with health insurance carriers. The company operates two reportable segments: Medicare (approximately 90% of revenue) and Employer and Individual (E&I). The business model relies on commissions from carriers for approved enrollments and fee-based business process outsourcing (BPO) services.
Key Financial Metrics
| Metric | 2024 | 2023 | Change |
|---|---|---|---|
| Total Revenue | $532.4 million | $452.9 million | +18% |
| Net Income | $10.1 million | $(28.2) million | Turnaround to Profit |
| Net Loss Attributable to Common Stockholders | $(35.0) million | $(66.5) million | Improvement |
| Operating Income | $23.6 million | $(29.1) million | Turnaround to Profit |
| Operating Cash Flow | $(18.4) million | $(6.7) million | Worsened |
| Cash & Short-term Investments | $82.2 million | $121.7 million | Decrease |
| Long-term Debt (Carrying Value) | $68.5 million | $67.8 million | Minimal Change |
Segment Performance: Medicare segment revenue grew 23% to $500.6 million, while E&I segment revenue declined 32% to $31.8 million. Medicare segment gross profit increased 52% to $191.5 million.
Material Changes vs. Prior Period
- Revenue Growth Drivers: Total revenue increased primarily due to a 26% rise in Medicare Advantage approved members and a 45% increase in "Other Revenue" (driven by fee-based BPO arrangements and sponsorship). This offset a decline in E&I commission revenue.
- Profitability Improvement: The company returned to net income and operating income in 2024 after losses in 2023, driven by operational efficiencies, improved lead quality, and higher Medicare Advantage constrained Lifetime Value (LTV) per member.
- One-Time Charges: The company incurred $9.5 million in impairment, restructuring, and other charges in 2024 (none in 2023), primarily related to $7.5 million in office lease impairments and $2.0 million in restructuring costs.
- Expense Management: General and administrative expenses decreased 10% due to lower headcount and facility costs. Technology and content expenses decreased 9%.
Guidance, Outlook, Risks, and Contingencies
- Outlook: Management plans to continue scaling the Medicare Advantage business and diversifying revenue through Medicare Supplement, ICHRA, and ancillary products. The company expects to maintain a steady benefit advisor count in 2025.
- Liquidity and Debt Covenants:
- The company has a $70 million term loan maturing in February 2026. As of December 31, 2024, it was in compliance with loan covenants.
- Preferred Stock Covenants: The company failed to maintain the Minimum Asset Coverage Ratio since September 2023 and was non-compliant with the Minimum Liquidity Amount as of November 30, 2024. This grants the preferred stock investor (H.I.G.) additional rights, including board nomination and budget approval, but does not trigger immediate redemption.
- Key Risks:
- Regulatory Changes: Significant uncertainty regarding CMS rules (e.g., CY 2025 Final Rules) and potential changes in Medicare reimbursement rates or broker compensation.
- Carrier Concentration: Revenue is highly concentrated; Humana, UnitedHealthcare, and Aetna accounted for 64% of total revenue in 2024.
- China Operations: Risks related to geopolitical tensions and data security regarding operations in Xiamen, China.
- Revenue Recognition: Reliance on complex estimates for constrained LTV of commissions, which involves significant judgment regarding member retention and conversion rates.
Investor Verification Checklist
- Preferred Stock Compliance: Verify the status of the Minimum Liquidity Amount and Asset Coverage Ratio covenants with H.I.G. Capital and the potential impact of their enhanced governance rights.
- Medicare Advantage LTV Assumptions: Review the specific assumptions used for constrained LTV calculations, particularly regarding member retention rates and the impact of recent CMS regulatory changes on future commission collections.
- Cash Flow Sustainability: Analyze the widening gap between net income and negative operating cash flow ($18.4M outflow), driven by increases in contract assets (commissions receivable).
- Carrier Concentration: Assess the risk exposure to the top three carriers (Humana, UnitedHealthcare, Aetna) and the potential impact of any relationship changes or commission rate adjustments.
- Debt Maturity: Confirm the refinancing strategy for the $70 million term loan maturing in February 2026, given the current liquidity constraints.